Pueraria mirifica for Health & Longevity - Quick Reference Sheet

Pueraria mirifica for Health & Longevity

Created on 10/18/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Pueraria mirifica is a Thai plant root, sold as a supplement, that acts as a strong plant estrogen; midlife women use it for menopausal changes. Small Thai studies show healthier vaginal tissue after menopause; hot-flash relief looked similar to prescription estrogen, but those trials lacked an inactive placebo. Main concerns are irregular bleeding and breast symptoms, mostly in younger users, and open questions about long-term breast and uterine safety. (Full Review)

Protocol

Oral root powder (trial regimen)
20–50 mg once daily
20, 30 or 50 mg for 24 weeks in placebo-controlled trials; 50–100 mg in an open trial; root powder, not an extract
Vaginal gel
0.5 g daily for 2 weeks
Then three times weekly for 10 weeks, for vaginal symptoms
Time of day
Morning, single daily dose
Morning dosing suggested by Examine; no data favor either timing
Time to effect
Vaginal tissue
4–12 weeks
Tissue changes with vaginal gel
Menopausal symptoms
Within 1 month
Symptom scores fell with oral root powder

Benefits

Contraindications
  • Pregnant or breastfeeding women
  • Girls and women under 18 years old
  • Women using hormonal contraceptives or prescription estrogen
  • People with inherited long QT syndrome
  • History of estrogen-sensitive breast or uterine cancer (theoretical)
  • Unexplained vaginal bleeding (theoretical)
  • History of blood clots in deep veins or lungs (theoretical)
  • Men trying to conceive (theoretical)
Key Interactions
  • Anti-estrogen cancer drugs (tamoxifen, letrozole, anastrozole): avoid (theoretical)
  • QT-prolonging drugs (citalopram, ondansetron, azithromycin): caution (theoretical)
  • CYP1A2 (a drug-clearing liver enzyme) substrates (drugs it clears: caffeine, theophylline, tizanidine, clozapine): monitor (theoretical)
  • Drugs that impair bile flow (bosentan, cyclosporine): caution (theoretical)
  • Thyroid hormone (levothyroxine): monitor (theoretical)
  • Over-the-counter medicines (high-dose loperamide, regular acetaminophen): caution (theoretical)
  • Other plant estrogens (soy isoflavones, red clover, kudzu, hops) and DHEA (dehydroepiandrosterone, a hormone precursor converted to estrogen): avoid stacking (theoretical)
  • Liver-stressing supplements (black cohosh, green tea extract, kava): caution (theoretical)
  • Surgery and prolonged immobilization: caution (theoretical)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Irregular vaginal bleeding, menstrual disorders and breast pain; heart-rhythm disturbance in people with an inherited heart-rhythm disorder; liver test and blood count abnormalities; digestive upset
  • Speculative: Promotion of breast or uterine cancer; suppression of reproductive hormones and fertility; blood clots; rise in C-reactive protein; genetic damage

Monitoring

Marker Target Why
ALT and AST ALT about 7–35 U/L; AST about 10–35 U/L Safety check: rising values stop use
Hemoglobin 12.0–15.5 g/dL in women Safety check: anemia was reported
Endometrial thickness No established target; track change from own baseline Safety check: thickening or bleeding stops use
QTc interval Below about 460 ms in women Safety check: prolongation stops use
LDL, HDL and triglycerides No established target; track change from own baseline Expected to change: mixed lipid effects reported
C-reactive protein (high-sensitivity) No established target; track change from own baseline Expected to change: a doubling was reported in trials
Vaginal maturation index No established target; track change from own baseline Expected to change: rises with estrogen-like effect on vaginal tissue

Cadence: Baseline, then 4 weeks, 3 months and 6 months, then every 6–12 months during continued use; liver enzymes and blood counts at 3 and 6 months, lipids at 3 months, ultrasound at 6 months or immediately with any bleeding, ECG 2–4 weeks after starting in at-risk people

Qualitative Assessment

  • Frequency and severity of hot flashes and night sweats
  • Vaginal dryness, irritation and comfort during intercourse
  • Sleep quality and mood
  • Breast tenderness or swelling
  • Any spotting, irregular or heavy bleeding